IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
24 hedge funds and large institutions have $8.68M invested in Interpace Biosciences, Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
24
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$221K | |
| 2 | +$104K | |
| 3 | +$7.56K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$5K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1K |
Top Sellers
| 1 | -$277K | |
| 2 | -$117K | |
| 3 | -$51K | |
| 4 |
PHS
Pekin Hardy Strauss
Chicago,
Illinois
|
-$26.6K |
| 5 |
Renaissance Technologies
New York
|
-$21.2K |